S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Funds/BVF Partners/Q4 2024

BVF Partners

Period: Q4 2024 Β· Filed: 2025-02-14
View on SEC EDGAR β†—
AUM
$2.95B
Total portfolio value
Positions
53
Reported securities
Top Holding
MLTX
36.3% $1.07B
QoQ Changes
+5 / -7
new Β· exited
⚠️13F Filing Disclosure

AUM figures shown are calculated by summing the reported market value of all positions in SEC 13F-HR filings β€” not the fund's actual assets under management.

  • Excludes cash, bonds, private equity, short positions, and foreign-listed stocks not required to be reported.
  • For PUT and CALL options, the reported Value is the notional value of the underlying shares β€” not the option premium paid. This significantly overstates the actual capital at risk.
  • Actual fund AUM is typically higher and includes strategies, instruments, and positions that never appear in a 13F.
  • 13F filings cover institutional managers with β‰₯$100M in 13F securities. Positions reflect end-of-quarter holdings, disclosed up to 45 days after the period ends.

Data sourced from SEC EDGAR. This tracker is for informational purposes only and does not constitute investment advice.

Portfolio Holdings

Top 30 positions

⚠️ Performance % calculated from filing date ( 2025-02-14) shown is the underlying stock price movement β€” not the derivative's P&L.
TickerIssuerNotionalPort %@ FilingNow (EOD)Since FilingAllocation
MLTXMOONLAKE IMMUNOTHERAPEUTICS$1.07B36.25%$54.15$18.95-65.0%
36.3%
KYMRKYMERA THERAPEUTICS INC$207.7M7.04%$40.23$113.51+182.2%
7.0%
RVMDREVOLUTION MEDICINES INC$182.9M6.20%$43.74$189.24+332.6%
6.2%
AXSMAXSOME THERAPEUTICS INC$117.4M3.98%$84.61$244.31+188.8%
4.0%
MIRMMIRUM PHARMACEUTICALS INC$115.6M3.92%$41.35$125.59+203.7%
3.9%
XOMAXOMA ROYALTY CORPORATION$95.5M3.24%$26.28$43.00+63.6%
3.2%
PTGXPROTAGONIST THERAPEUTICS INC$73.3M2.49%$38.60$131.62+241.0%
2.5%
GHRSGH RESEARCH PLC$72.8M2.47%$7.00$27.01+285.9%
2.5%
CGEMCULLINAN THERAPEUTICS INC$70.0M2.37%$12.18$17.63+44.8%
2.4%
ZYMEZYMEWORKS INC$63.1M2.14%$14.64$26.31+79.7%
2.1%
SEPNSEPTERNA INC$56.1M1.90%$22.90$34.00+48.5%
1.9%
TYRATYRA BIOSCIENCES INC$54.8M1.86%$13.90$30.62+120.3%
1.9%
ACIUAC IMMUNE SA$52.7M1.79%$2.70$2.51-7.0%
1.8%
XNCRXENCOR INC$52.6M1.78%$22.98$15.00-34.7%
1.8%
GPCRSTRUCTURE THERAPEUTICS INC$48.0M1.63%$27.12$53.45+97.1%
1.6%
CELCCELCUITY INC$45.4M1.54%$13.09$107.95+724.7%
1.5%
LKFTGALAPAGOS NV$43.2M1.46%$27.50$30.39+10.5%
1.5%
VERVVERVE THERAPEUTICS INC$38.9M1.32%β€”β€”
1.3%
ANNXANNEXON INC$35.9M1.22%$5.13$5.46+6.4%
1.2%
AGIOAGIOS PHARMACEUTICALS INC$35.3M1.20%$32.86$37.58+14.4%
1.2%
ETNB89BIO INC$33.9M1.15%β€”β€”
1.1%
OLMAOLEMA PHARMACEUTICALS INC$33.3M1.13%$5.83$12.64+116.8%
1.1%
CDTXCIDARA THERAPEUTICS INC$29.4M1.00%β€”β€”
1.0%
ELDNELEDON PHARMACEUTICALS INC$25.9M0.88%$4.12$3.95-4.1%
0.9%
FHTXFOGHORN THERAPEUTICS INC$25.0M0.85%$4.72$5.30+12.3%
0.8%
THRDTHIRD HARMONIC BIO INC$24.4M0.83%β€”β€”
0.8%
KURAKURA ONCOLOGY INC$22.4M0.76%$8.71$11.10+27.4%
0.8%
ALLKALLAKOS INC$20.0M0.68%β€”β€”
0.7%
GLUEMONTE ROSA THERAPEUTICS INC$19.2M0.65%$6.94$24.21+248.8%
0.7%
ITOSITEOS THERAPEUTICS INC$17.9M0.61%β€”β€”
0.6%

Quarter-on-Quarter Activity

Q4 2024 vs. Q3 2024

New Positions (5)

TickerIssuerNotionalSince Filing
SEPNSEPTERNA INC$56.1M+48.5%
GLUEMONTE ROSA THERAPEUTICS INC$19.2M+248.8%
ITOSITEOS THERAPEUTICS INC$17.9M
RAPTRAPT THERAPEUTICS INC$14.6M
PVLAPALVELLA THERAPEUTICS INC NE$8.4M

Exited Positions (7)

TickerIssuerNotional
IONSIONIS PHARMACEUTICALS INC$58.2M
IDYAIDEAYA BIOSCIENCES INC$44.7M
CGONCG ONCOLOGY INC$37.5M
NAMSNEWAMSTERDAM PHARMA COMPANY$25.3M
VTGNVISTAGEN THERAPEUTICS INC$6.0M
PIRSPIERIS PHARMACEUTICALS INC$4.3M
MTEMMOLECULAR TEMPLATES INC$0.7M

Increased (8)

TickerIssuerNotionalShares Ξ”Since Filing
VERVVERVE THERAPEUTICS INC$35.8M+962.2%
FBRXFORTE BIOSCIENCES INC$12.8M+398.2%
MOLNMOLECULAR PARTNERS AG$4.3M+205.5%
XNCRXENCOR INC$35.5M+169.3%-34.7%
CDTXCIDARA THERAPEUTICS INC$21.8M+55.4%
AXSMAXSOME THERAPEUTICS INC$23.4M+32.7%+188.8%
VSTMVERASTEM INC$5.8M+24.6%
RVMDREVOLUTION MEDICINES INC$25.1M+20.2%+332.6%

Trimmed (8)

TickerIssuerNotionalShares Ξ”Since Filing
FDMT4D MOLECULAR THERAPEUTICS IN$-64.9M-63.8%
THRDTHIRD HARMONIC BIO INC$-34.7M-45.6%
OLMAOLEMA PHARMACEUTICALS INC$-75.8M-37.4%+116.8%
ETNB89BIO INC$-16.5M-36.4%
KURAKURA ONCOLOGY INC$-43.5M-23.9%+27.4%
GPCRSTRUCTURE THERAPEUTICS INC$-50.2M-20.9%+97.1%
IKNAIKENA ONCOLOGY INC$-1.7M-16.0%
TYRATYRA BIOSCIENCES INC$-54.8M-15.4%+120.3%
← Back to Hedge Funds